Walnut Consumption, Plasma Metabolomics, and Risk of Type 2 Diabetes and Cardiovascular Disease | Zendy

Marta GuaschFerré | Zendy; Pablo HernándezAlonso | Zendy; JeanPhilippe DrouinChartier | Zendy; Miguel RuizCanela | Zendy; Cristina Razquín | Zendy; Estefanía Toledo | Zendy; Jun Li | Zendy; Courtney Dennis | Zendy; Clemens Wittenbecher | Zendy; Dolores Corella | Zendy; Ramón Estruch | Zendy; Montserrat Fitó | Zendy; Emilio Ros | Zendy; Nancy Babió | Zendy; Shilpa N. Bhupathiraju | Zendy; Clary B. Clish | Zendy; Liming Liang | Zendy; Miguel Ángel MartínezGonzález | Zendy; Frank B. Hu | Zendy; Jordi SalasSalvadó | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Walnut Consumption, Plasma Metabolomics, and Risk of Type 2 Diabetes and Cardiovascular Disease

Author(s) -

Marta GuaschFerré,

Pablo HernándezAlonso,

JeanPhilippe DrouinChartier,

Miguel RuizCanela,

Cristina Razquín,

Estefanía Toledo,

Jun Li,

Courtney Dennis,

Clemens Wittenbecher,

Dolores Corella,

Ramón Estruch,

Montserrat Fitó,

Emilio Ros,

Nancy Babió,

Shilpa N. Bhupathiraju,

Clary B. Clish,

Liming Liang,

Miguel Ángel MartínezGonzález,

Frank B. Hu,

Jordi SalasSalvadó

Publication year - 2020

Publication title -

journal of nutrition

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.463

H-Index - 265

eISSN - 1541-6100

pISSN - 0022-3166

DOI - 10.1093/jn/nxaa374

Subject(s) - type 2 diabetes , disease , medicine , diabetes mellitus , metabolomics , endocrinology , physiology , bioinformatics , biology

Walnut consumption is associated with lower risk of type 2 diabetes (T2D) and cardiovascular disease (CVD). However, it is unknown whether plasma metabolites related to walnut consumption are also associated with lower risk of cardiometabolic diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research